This inventor holds 1 USPTO granted patent. Top assignee: Hafslund Nycomed A/s. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Paul D Edminson: Innovator in Medical Treatment
Introduction
Paul D Edminson is a notable inventor based in Rykkinn, Norway. He has made significant contributions to the field of medical treatment, particularly in the area of intestinal health. His innovative approach has led to the development of a unique method for treating lesions in the large intestinal epithelium.
Latest Patents
Edminson holds a patent for a method aimed at treating hyperproliferative benign or malignant lesions in the large intestinal epithelium. This method involves administering the tripeptide L-pyroglutamyl-L-histidyl-glycine, which is designed to improve patient outcomes in gastrointestinal health. His patent is a testament to his dedication to advancing medical science.
Career Highlights
Throughout his career, Edminson has worked with Hafslund Nycomed A/S, a company known for its focus on pharmaceutical innovations. His work has been instrumental in developing new treatment methodologies that address critical health issues. With a patent portfolio that includes 1 patent, he continues to push the boundaries of medical research.
Collaborations
Edminson has collaborated with notable colleagues such as Oyvind Skraastad and Tellef Fossli. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
Paul D Edminson is a distinguished inventor whose work in medical treatment has made a significant impact. His innovative methods and collaborations highlight his commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile